Boosting Leukemia Survival
Umbilical cord blood transplants may lead to high survival in patients with leukemia who are at high risk for relapse post-transplant, a new study found.
In Early Tests, Blood, Bone Marrow Rx Sparked Hope
Early testing of a medication for blood cancers and bone marrow disorders yielded promising results. Now, researchers are looking to the future.
Great Leaps in Leukemia Treatment
Cancer research has led to longer lives and better quality of life for millions of people. This year, the transformation of leukemia treatment has been singled out as the “Advance of the Year.”
FDA Approves New Cancer Medication
The US Food and Drug Administration (FDA) approved Zydelig (idelalisib) today to treat patients with three types of blood cancers.
Why Childhood Cancer Survival Rates Have Increased
With increasing survival rates for many types of childhood cancers, some of these cancers are approaching cures. Several key events have made this possible.
Study Finds Promising Treatment for Myelofibrosis
Myelofibrosis is a type of chronic leukemia that attacks bone marrow. Researchers at Mayo Clinic showed promising study results for one treatment for this disease.
Banned Rx May Save Young Lives
A medication taken off the market in 2010 may have a new use in treating children with an aggressive form of blood cancer.
News Childhood Cancer Survivors Can Take to Heart
Therapies that are successful in wiping out childhood leukemia can impact the health of survivors years down the road. New research found that heart problems can begin to appear in survivors even during childhood.
New Thinking on Childhood Cancer Survivors
Thanks to treatment advances, the vast majority of children diagnosed with leukemia are living well into adulthood. But the powerful treatment, while effective against the cancer, can cause some health problems later in life. A new study looked at the treatment-related effects on survivors’ mental functions.
FDA Asks for Halt in Sales of Blood Cancer Rx
The US Food and Drug Administration (FDA) has asked the maker of a medication that has been used to treat two types of leukemia to stop selling that product.